Resultados da pesquisa por Autor

1

An Intravenous Stimulus Package for Oncolytic Virotherapy

An Intravenous Stimulus Package for Oncolytic Virotherapy

Por Vile, Richard, Melcher, Alan
Publicado em 2011

Obter o texto integral
Obter o texto integral
Obter o texto integral

Artigo

2

Oncolytic Viruses: Time to Compare, Contrast, and Combine?: 5th International Meeting on Replicating Oncolytic Virus Therapeutics Banff, Alberta, Canada, 18–22 March 2009

Oncolytic Viruses: Time to Compare, Contrast, and Combine?: 5th International Meeting on Replicating Oncolytic Virus Therapeutics Banff, Alberta, Canada, 18–22 March 2009

Por Pandha, Hardev, Melcher, Alan, Harrington, Kevin, Vile, Richard
Publicado em 2009

Obter o texto integral
Obter o texto integral
Obter o texto integral

Artigo

3

Live viruses to treat cancer

Live viruses to treat cancer

Por Donnelly, Oliver, Harrington, Kevin, Melcher, Alan, Pandha, Hardev
Publicado em 2013

Obter o texto integral
Obter o texto integral
Obter o texto integral

Artigo

4

Thunder and Lightning: Immunotherapy and Oncolytic Viruses Collide

Thunder and Lightning: Immunotherapy and Oncolytic Viruses Collide

Por Melcher, Alan, Parato, Kelley, Rooney, Cliona M, Bell, John C
Publicado em 2011

Obter o texto integral
Obter o texto integral
Obter o texto integral

Artigo

5

The Hitchhiker's Guide to Virotherapy

The Hitchhiker's Guide to Virotherapy

Por Donnelly, Oliver, Vile, Richard, Pandha, Hardev, Harrington, Kevin, Melcher, Alan
Publicado em 2012

Obter o texto integral
Obter o texto integral

Artigo

6

What new immunotherapeutic techniques are currently being investigated for the treatment of melanoma?

What new immunotherapeutic techniques are currently being investigated for the treatment of melanoma?

Por Donnelly, Oliver G, Melcher, Alan A, Vile, Richard G, Pulido, Jose
Publicado em 2012

Obter o texto integral
Obter o texto integral
Obter o texto integral

Artigo

7

Cancer immunotherapy via combining oncolytic virotherapy with chemotherapy: recent advances

Cancer immunotherapy via combining oncolytic virotherapy with chemotherapy: recent advances

Por Simpson, Guy R, Relph, Kate, Harrington, Kevin, Melcher, Alan, Pandha, Hardev
Publicado no Oncolytic Virother (2016)

Obter o texto integral
Obter o texto integral
Obter o texto integral

Artigo

8

Cell Carriers for Oncolytic Viruses: Fed Ex for Cancer Therapy

Cell Carriers for Oncolytic Viruses: Fed Ex for Cancer Therapy

Por Willmon, Candice, Harrington, Kevin, Kottke, Timothy, Prestwich, Robin, Melcher, Alan, Vile, Richard
Publicado em 2009

Obter o texto integral
Obter o texto integral
Obter o texto integral

Artigo

9

Phase I/II storm study: Intravenous delivery of a novel oncolytic immunotherapy agent, Coxsackievirus A21, in advanced cancer patients

Phase I/II storm study: Intravenous delivery of a novel oncolytic immunotherapy agent, Coxsackievirus A21, in advanced cancer patients

Por Pandha, Hardev, Harrington, Kevin, Ralph, Christy, Melcher, Alan, Grose, Mark, Shafren, Darren
Publicado no J Immunother Cancer (2015)

Obter o texto integral
Obter o texto integral

Artigo

10

Differential effects of Paclitaxel on dendritic cell function

Differential effects of Paclitaxel on dendritic cell function

Por John, Justin, Ismail, Mohammed, Riley, Catherine, Askham, Jonathan, Morgan, Richard, Melcher, Alan, Pandha, Hardev
Publicado em 2010

Obter o texto integral
Obter o texto integral
Obter o texto integral

Artigo

11

Oncolytic Viruses: Do They Have a Role in Anti-Cancer Therapy?

Oncolytic Viruses: Do They Have a Role in Anti-Cancer Therapy?

Por Prestwich, Robin J, Errington, Fiona, Harrington, Kevin J., Pandha, Hardev S., Selby, Peter, Melcher, Alan
Publicado em 2008

Obter o texto integral
Obter o texto integral

Artigo

12

Autologous versus allogeneic peptide-pulsed dendritic cells for anti-tumour vaccination: expression of allogeneic MHC supports activation of antigen specific T cells, but impairs early naïve cytotoxic priming and anti-tumour therapy

Autologous versus allogeneic peptide-pulsed dendritic cells for anti-tumour vaccination: expression of allogeneic MHC supports activation of antigen specific T cells, but impairs e...

Por Merrick, Alison, Diaz, Rosa Maria, O’Donnell, Dearbhaile, Selby, Peter, Vile, Richard, Melcher, Alan
Publicado em 2007

Obter o texto integral
Obter o texto integral
Obter o texto integral

Artigo

13

Evidence for Oncolytic Virotherapy: Where Have We Got to and Where Are We Going?

Evidence for Oncolytic Virotherapy: Where Have We Got to and Where Are We Going?

Por Turnbull, Samantha, West, Emma J., Scott, Karen J., Appleton, Elizabeth, Melcher, Alan, Ralph, Christy
Publicado no Viruses (2015)

Obter o texto integral
Obter o texto integral
Obter o texto integral

Artigo

14

Applications of coxsackievirus A21 in oncology

Applications of coxsackievirus A21 in oncology

Por Bradley, Stephen, Jakes, Adam D, Harrington, Kevin, Pandha, Hardev, Melcher, Alan, Errington-Mais, Fiona
Publicado no Oncolytic Virother (2014)

Obter o texto integral
Obter o texto integral
Obter o texto integral

Artigo

15

Heat shock protein derived from a non-autologous tumour can be used as an anti-tumour vaccine

Heat shock protein derived from a non-autologous tumour can be used as an anti-tumour vaccine

Por Casey, David G, Lysaght, Joanne, James, Tharappel, Bateman, Andrew, Melcher, Alan A, Todryk, Stephen M
Publicado em 2003

Obter o texto integral
Obter o texto integral
Obter o texto integral

Artigo

16

VSV Oncolytic Virotherapy in the B16 Model Depends Upon Intact MyD88 Signaling

VSV Oncolytic Virotherapy in the B16 Model Depends Upon Intact MyD88 Signaling

Por Wongthida, Phonphimon, Diaz, Rosa M, Galivo, Feorillo, Kottke, Timothy, Thompson, Jill, Melcher, Alan, Vile, Richard
Publicado em 2011

Obter o texto integral
Obter o texto integral
Obter o texto integral

Artigo

17

Oncolytic viruses: a novel form of immunotherapy

Oncolytic viruses: a novel form of immunotherapy

Por Prestwich, Robin J, Harrington, Kevin J, Pandha, Hardev S, Vile, Richard G, Melcher, Alan A, Errington, Fiona
Publicado em 2008

Obter o texto integral
Obter o texto integral
Obter o texto integral

Artigo

18

OP03 ONCOLYTIC HERPES SIMPLEX VIRUS INHIBITS PAEDIATRIC HIGH GRADE GLIOMA AND DIFFUSE INTRINSIC PONTINE GLIOMA MIGRATION AND INVASION; MECHANISM AND POTENTIAL FOR CLINICAL APPLICATION

OP03 ONCOLYTIC HERPES SIMPLEX VIRUS INHIBITS PAEDIATRIC HIGH GRADE GLIOMA AND DIFFUSE INTRINSIC PONTINE GLIOMA MIGRATION AND INVASION; MECHANISM AND POTENTIAL FOR CLINICAL APPLICAT...

Por Cockle, Julia V., Ilett, Elizabeth, Brüning-Richardson, Anke, Scott, Karen, Picton, Susan, Short, Susan, Melcher, Alan
Publicado no Neuro Oncol (2015)

Obter o texto integral
Obter o texto integral

Artigo

19

Single-Cycle Viral Gene Expression, Rather Than Progressive Replication and Oncolysis, Is Required for VSV Therapy of B16 Melanoma

Single-Cycle Viral Gene Expression, Rather Than Progressive Replication and Oncolysis, Is Required for VSV Therapy of B16 Melanoma

Por Galivo, Feorillo, Diaz, Rosa Maria, Wongthida, Phonphimon, Thompson, Jill, Kottke, Timothy, Barber, Glen, Melcher, Alan, Vile, Richard
Publicado em 2009

Obter o texto integral
Obter o texto integral
Obter o texto integral

Artigo

20

Optimization of Dendritic Cell Loading With Tumor Cell Lysates for Cancer Immunotherapy

Optimization of Dendritic Cell Loading With Tumor Cell Lysates for Cancer Immunotherapy

Por Hatfield, Paul, Merrick, Alison E., West, Emma, O’Donnell, Dearbhaile, Selby, Peter, Vile, Richard, Melcher, Alan A.
Publicado em 2008

Obter o texto integral
Obter o texto integral
Obter o texto integral

Artigo

1
2
3
4
Seguinte
[4]